These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26139305)

  • 21. Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases.
    Hatzara C; Hadziyannis E; Kandili A; Koutsianas C; Makris A; Georgiopoulos G; Vassilopoulos D
    Ann Rheum Dis; 2015 Oct; 74(10):1848-53. PubMed ID: 24854354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study.
    Muñoz L; Casas S; Juanola X; Bordas X; Martinez C; Santin M;
    Clin Infect Dis; 2015 Feb; 60(3):349-56. PubMed ID: 25313252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region.
    Kumar P; Vuyyuru SK; Kante B; Sahu P; Goyal S; Madhu D; Jain S; Ranjan MK; Mundhra S; Golla R; Singh M; Virmani S; Gupta A; Yadav N; Kalaivani M; Sharma R; Das P; Makharia G; Kedia S; Ahuja V
    Aliment Pharmacol Ther; 2022 Jun; 55(11):1431-1440. PubMed ID: 35229906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
    Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.
    Chiu HY; Hsueh PR; Tsai TF
    Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
    Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
    Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease.
    Swaminath A; Bhadelia N; Wang YC
    Inflamm Bowel Dis; 2013 Oct; 19(11):2444-9. PubMed ID: 23945184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?
    Cabriada JL; Ruiz-Zorrilla R; Barrio J; Atienza R; Huerta A; Rodríguez-Lago I; Bernal A; Herrero C
    Turk J Gastroenterol; 2018 May; 29(3):292-298. PubMed ID: 29755013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Shahidi N; Fu YT; Qian H; Bressler B
    Inflamm Bowel Dis; 2012 Nov; 18(11):2034-42. PubMed ID: 22294550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroids and immunosuppressive therapy influence the result of QuantiFERON TB Gold testing in inflammatory bowel disease patients.
    Helwig U; Müller M; Hedderich J; Schreiber S
    J Crohns Colitis; 2012 May; 6(4):419-24. PubMed ID: 22398067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease.
    Schoepfer AM; Flogerzi B; Fallegger S; Schaffer T; Mueller S; Nicod L; Seibold F
    Am J Gastroenterol; 2008 Nov; 103(11):2799-806. PubMed ID: 18684188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Al-Taweel T; Strohl M; Pai M; Martel M; Bessissow T; Bitton A; Seidman E; Afif W
    Dig Dis Sci; 2018 Oct; 63(10):2695-2702. PubMed ID: 29968143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon Gamma Release Assay-Guided Latent Tuberculosis Prophylaxis in Israel.
    Fireman-Klein E; Man A; Schwartz Y; Fireman E
    Isr Med Assoc J; 2015 Jul; 17(7):405-9. PubMed ID: 26357713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Amorim RF; Viegas ERC; Carneiro AJV; Esberard BC; Chinem ES; Correa RS; Rodrigues L; Ribeiro-Alves M; Silva KS; de Souza HS; Carvalho ATP
    Dig Dis Sci; 2019 Jul; 64(7):1916-1922. PubMed ID: 30673986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study.
    Garcovich S; Ruggeri A; D'Agostino M; Ardito F; De Simone C; Delogu G; Fadda G
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1572-6. PubMed ID: 21923840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
    Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the use of the interferon-γ response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-α therapy: a prospective head-to-head cross-sectional study.
    Martyn-Simmons CL; Mee JB; Kirkham BW; Groves RW; Milburn HJ
    Br J Dermatol; 2013 May; 168(5):1012-8. PubMed ID: 23278714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab.
    Vortia E; Uko VE; Yen-Lieberman B; Frawley J; Worley SE; Danziger-Isakov L; Kaplan B; Mahajan L
    Inflamm Bowel Dis; 2018 Mar; 24(4):877-882. PubMed ID: 29562270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients.
    Sayarlioğlu H; Gül M; Eren Dağli C; Doğan E; Sahin M; Uçar MA; Köksal N; Sayarlioğlu M; Tahta MK
    Tuberk Toraks; 2011; 59(2):105-10. PubMed ID: 21740383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.